WHO ICTRP trial
Gabapentin and dexclorfeniramine in the treatment of pruritus in hemodialysis…
RBR-4rxr2c · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-4rxr2c |
|---|---|
| Public title | Gabapentin and dexclorfeniramine in the treatment of pruritus in hemodialysis patients |
| Scientific title | Gabapentin versus dexclorfeniramine in the treatment of uremic pruritus in hemodialysis patients: a randomized clinical trial, double-blind and controlled |
| Primary sponsor | Faculdade de Medicina de Botucatu |
| Secondary sponsors | Fundo de Apoio à Dermatologia de São Paulo |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | Chronic Renal Insufficiency , hemodialysis, uremic pruritus.;C17.800.685 |
| Interventions | Participants (n=71) with persistent itching, will be provided the Cold cream (topical product- intervention) with use of 2 times a day,in the whole body, for 15 days. After this period, the participants still with persistent itching of any… |
| Registration date | Nov 7, 2016 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: